Investor Statement
Access to Medicine Index
The goal of investors is to create long-term shareholder value in the companies in which they invest.
This potential is maximized by investing in well-managed, high quality companies, where the management team have considered fully the range of business risks and opportunities facing their companies,
and taken appropriate action to manage these. Alongside assessment of traditional financial risks andopportunities, there is growing recognition among the investment community of the potential for environmental, social and governance (ESG) factors to impact the financial performance of companies. Assuch, investors are also seeking for companies to demonstrate effective management of ESG factors.
We believe the issue of access to medicine in developing countries can present potentially significant
business impacts for global companies in the pharmaceutical sector. As greater emphasis is placed onaccessing new markets as a source for future industry growth, pharmaceutical companies are brought
into ever closer contact with access to medicine issues in developing countries. Mismanagement ofthese issues can impact negatively on political relationships and corporate brands and encumber
market access. On the other hand, if pharmaceutical companies act responsibly and with foresight,
commercial potential can be unlocked.
As investors, we seek assurances that the management of the companies in which we invest havefully considered the risks and opportunities of this issue, and have effective policies and processes fordealing with the challenges. By taking management of this issue into account, alongside other key ESG
and financial issues, the investment community can better assess the long-term investment value ofsuch companies. We are increasingly reviewing corporate approaches to access to medicine and associated aspects of intellectual property as a key strategic consideration in our analysis of the sector, where
this is appropriate to do so.
It is in this context that the investors listed below welcome the development of analytical tools such as
the Access to Medicine Index, which may be used by investors to assess companies’ management of theissue, based on information obtained from their reporting activities.
By our explicit inclusion in this statement, we are agreed on the following:• We believe the issue of access to medicine is potentially material to long-term shareholder value
creation, and is a potentially relevant consideration when forming views on the strategic positioningof companies in the pharmaceutical sector. We welcome the Access to Medicine ­Foundation’s efforts
to develop a credible, transparent and independent tool, which could be useful with regards to specificissue;• We consider that pharmaceutical companies have an important role to play in addressing the access tomedicine issue;• We will review and take into account the analysis generated from the Index as appropriate in the ESG
analysis we conduct on the companies we invest in;• We hope that the Index will contribute towards creating greater awareness within the industry of thisimportant issue, and act as a tool for highlighting leadership and good practice, as well as gaps andchallenges;• We will provide investor input into the evolution of the Index to ensure it considers the investment
perspective as appropriate and remains dynamic and relevant to the debate.
We would encourage other investors to join us in this statement.

SIG NATO RY I NVESTORSTOTAL ASSETS UNDER MANAGEMENT IN EXCESS OF USD 21 TRILLION
For more information please contact Suzi van Es
svanes@accesstomedicinefoundation.org+ 31 (0) 20 21 53 535
Updated June 2024

CO NTACTS
Investor

Signatory Contact

Aberdeen Standard Investments
Andrew Mason
AchmeaJeroen Wiercx
Adrian Dominican Sisters
Donna Meyer
Aegon Investment Management
Heike Cosse
Aequo and Hexavest
Arnaud Celka
Aikya Investment Management
Tom Allen
AlectaPeter Loow
AllianceBernstein
Saskia Kort-Chick
American Century Investments
Guillaume MascottoAmundi Asset Management
Caroline Le Meaux
APG Asset Management
Els Knoope
Apostle Funds Management
Fiona Manning
ASN Beleggingsfondsen
Piet Sprengers
ASR Nederland NV
Jack Julicher
Asset Management One
Toru Terasawa
Auriga Partners
Jacques Chatain
Australian Ethical Investment
Stuart Palmer
Aviva Investors
Steve Waygood
AXA Investment Managers
Gilles Moec
BancoPosta Fondi S.p.A. SGR
Stefano Giuliani
BNP Paribas Investment Partners
Helena Vines Fiestas
Bon Secours Mercy HealthDonna Meyer
Boston Common Asset Management
Lauren Compere
Boston Trust Walden Company
Heidi Soumerai
Calvert Research and Management
Stuart Dalheim
Candriam Investors Group
Sophie Deleuze
CardanoColette Grosscurt
Castlefield Investment Partners
Mark Elliot
CCLA Investment Management
Amy Browne
Central Finance Board of the Methodist Church Christophe Borysiewicz
Church of Sweden
Sara Nordbrand
ClearBridge Investments
Marshall Gordon
Coho Partners
Nimrit Kang
Columbia Threadneedle Investments
Catherine McCabe
Cometa Pension Fund
Maurizio Agazzi
ComgestSebastien Thevoux-Chabuel
Coöperatie VGZ UA
Erik Jan van Bergen
C-QUADRAT Asset Management GmbHGünther Kastner
Crédit Mutuel Asset Management
Isabelle Delattre
CZ Fund Management BV
Yvo Boon
Dana Investment Advisors
Ann Roberts
Daughters of Charity, Province of St. Louise Donna Meyer
Decatur Capital Management, Inc.
Rosanne Lissow
Dignity HealthDonna Meyer
DNB Asset Management
Lise Børresen
Domini Impact Investments LLC
Carole Laible
ECO Advisors
Roz Yazdan
Ecofi Investissements
Francois Lett
EdenTree Investment Management
Ketan Patel
Edmond de Rothschild Asset Management
Adeline Salat-Baroux(France)
EFG Asset Management
Stefano Montobbio
EGAMO
Jérôme Tendeau
EOS at Federated Hermes
Kimberley Lewis
Epworth Investment Management
Christophe Borysiewicz
EQ Investors
Lousiana Salge
Ethical Partners Funds Management
Robyn Parkin
Ethos
Vincent Kaufmann
Etica Sgr - Responsible Investments
Luca Mattiazzi
Fondita Fund Management Company
Janna Haahtela
Forma Futura AG
Doris Hauser
GAM Investments
Mark HarlandGreenbank
Matt Crossman
Groupama AM
Jana Celeste
Groupe MACSF
Luc Deschamps
Harmonie Mutuelle
Aurelien Bon
Hexavest
Jo-Annie Pinto
HSBC Asset Management
Christine Chow,
Ibercaja Gestión
Miriam Fernández Jiménez
ICCR
Meg Jones-Monteiro
Impax Asset Management and Pax World Funds Evie Paterson
Indecap
Mats Lagerqvist
J. Safra Sarasin
Jullia Wittenberg
Janus Henderson
Antony Marsden
Jennison Associates LLC
Linda GalsimInvestor

Signatory Contact

JLens Investment Network
Rabbi Joshua RatnerJoh. Berenberg, Gossler & Co. KG (­ Berenberg) Dr. Rupini Rajagopalan
Kempen Capital Management
Eszter Vitorino
Kieger AG
Panagiota Balfousia
La Banque Postale Asset Management
Luisa Florez
La Financiere de l'Echiquier
Coline Pavot
Länsförsäkringar AB
Kristofer Dreiman
Legal & General Investment Management
Maria Larsson Ortino
Local Government Super
Moya Yip
M&G Investments
Ben Constable Maxwell
Mercy Investment Services
Donna Meyer
Miller/Howard Investments
Luan Steinhilber
MirovaManon Salomez
Mitsubishi UFJ Trust and Banking Corporation Masahiro Kato
MN
Louis KranenburgNatixis
Marina Iodice
NEI Investments
Jamie Bonham
Ninety One
Stephanie Niven
NN Investment Partners
Adrie Heinsbroek
Nomura Asset Management
Toshiyuki Imamura
Nordea Asset Management
Magdalena Kettis
Northwest Coalition for Responsible I­ nvestment Timnit Ghermay
OFI Asset Management
Eric Van La BeckÖhmanFredric Nystrom
Parnassus Investments
Benjamin Allen
Pax World Funds
Joe Keefe
Pensioenfonds Medewerkers Apotheken (PMA) Remco Velasquez
PGGM
Rogier Snijdewind
Poste Vita S.p.A.
Antonio Colombi
Quaestio Capital SGR Spa
Mario Baronci
Radicant Bank AG
Eve Morelli
RAM Active Investments SA
Cyrille Joye
Redwheel
Chris Anker
Reynders, McVeigh Capital Management, LLC Maria Egan
RobecoPeter van der Werf
Royal London Asset Management
Ashley Claxton
Schroders
Seema Suchak
SEB Investment Management AB
Anette Andersson
SPH
Bram Stageman
SPMS
Marcel Roberts
Stewart Investors
Jennifer Stephen
Stichting Algemeen Pensioenfonds U­ nilever Willy Westerborg
NederlandStorebrand Asset Management
Matthew Smith
Sumitomo Mitsui Trust Asset Management
Seiji Kawazoe
Swedbank Robur Fonder AB
Pia Gisgård
Sycomore Asset Management
Bertille Knuckey
T. Rowe PriceMaria Elena Drew
The Congregation of St. JosephDonna Meyer
The Dai-ichi Life Insurance Company, Limited Hiroko Ishii
The Sisters of St. Francis of Philadelphia
Nora Nash
The Socially Responsible Investing Group of Alison Bevilacqua
1919 Investment Counsel
The Sustainability Group of Loring, W­ olcott Larisa Ruoff& Coolidge
Tokio Marine Asset Management Co., Ltd.
Yo Mizuno
Trillium Asset Management
Jonas Kron
Trinity Health
Cathy Rowan
Triodos Investment Management
Erik Breen
Trusteam Finance
Claire Berthier
Unigestion
Eric Cockshutt
Union Investment
Dr. Henrik Pontzen
United Church Funds
Charles BuckUSS
Daniel Summerfield
Valori Asset Management
Giancarlo FragomenoVancity Investment Management
Kelly Hirsch
Varma Mutual Pension Insurance ­Company
Kaisa Ojainmaa
Vontobel
Natalia Ernst
VvAA Groep B.V.
Christel de Groot
VvAA Schadeverzekeringen N.V.
Christel de Groot
Wesleyan Group
Milly Mcloughlin
WHEB Asset Management
Seb Beloe
Zevin Asset Management
Pat Miguel Tomaino
Zürcher Kantonalbank
Dr. Jürgen Siemer
Updated June 2024